Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
45.06
+0.23 (0.51%)
At close: Mar 9, 2026, 4:00 PM EDT
44.24
-0.82 (-1.82%)
After-hours: Mar 9, 2026, 5:18 PM EDT
Maze Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.06 | 0.14 | 4.94 | 0.32 |
| Debt / EBITDA Ratio | - | 0.40 | - | - |
| Debt / FCF Ratio | - | 0.36 | - | - |
| Net Debt / Equity Ratio | -0.95 | -0.86 | 2.04 | -0.67 |
| Net Debt / EBITDA Ratio | 2.73 | -2.79 | -0.22 | 0.63 |
| Net Debt / FCF Ratio | 3.33 | -2.27 | -0.23 | 0.67 |
| Asset Turnover | - | 1.07 | - | - |
| Quick Ratio | 17.40 | 9.52 | 1.79 | 4.81 |
| Current Ratio | 17.70 | 9.76 | 2.09 | 5.11 |
| Return on Equity (ROE) | -52.69% | 50.48% | -180.12% | - |
| Return on Assets (ROA) | -27.37% | 23.07% | -55.63% | - |
| Return on Invested Capital (ROIC) | -634.89% | 196.80% | -307.50% | -330.64% |
| Return on Capital Employed (ROCE) | -33.60% | 26.20% | -178.60% | -86.00% |
| Buyback Yield / Dilution | -1176.31% | -19.33% | -13.82% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.